Impact of ETI Treatment on IDAA1c in Adults with CFRD
Publié par：Unknown
·Publié le : 2025-12-13
Discussion regarding the effects of elexacaftor-tezacaftor-ivacaftor (ETI) treatment on insulin dose-adjusted hemoglobin A1c (IDAA1c) in adults with cystic fibrosis-related diabetes (CFRD) over a 24-month period.
Chargement...